Name: UMIN ID:
Unique ID issued by UMIN | UMIN000032829 |
---|---|
Receipt number | R000037238 |
Scientific Title | Japanese Anti-Coagulation Regimen Exploration in AF Catheter Ablation Registry - Rivaroxaban cohort Extension |
Date of disclosure of the study information | 2018/06/01 |
Last modified on | 2020/11/25 22:45:13 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/06/01 13:57:29 | ||
2 | Update | 2018/06/01 14:01:42 | Recruitment status |
|
3 | Update | 2018/06/22 13:28:31 | Institute |
|
4 | Update | 2018/06/22 13:30:44 | Name of primary person or sponsor |
|
5 | Update | 2019/01/31 16:55:46 | Date of closure to data entry |
|
6 | Update | 2019/06/03 14:29:06 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Zip code Organization Organization Address Address Tel |
|
7 | Update | 2019/06/03 14:29:59 | Date of IRB Last follow-up date |
|
8 | Update | 2020/11/17 08:36:44 | Recruitment status Date trial data considered complete Date analysis concluded |
|
9 | Update | 2020/11/17 09:25:50 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
10 | Update | 2020/11/17 09:40:23 | Baseline Characteristics Baseline Characteristics |
|
11 | Update | 2020/11/17 09:40:46 | Publication of results |
|
12 | Update | 2020/11/17 11:55:24 | Results Results Baseline Characteristics Baseline Characteristics |
|
13 | Update | 2020/11/17 12:26:30 | Results Baseline Characteristics |
|
14 | Update | 2020/11/25 22:45:13 | Results Participant flow Outcome measures |